Finance

Lists
300529:SHE
Jafron Biomedical Co Ltd
CNยฅ20.14
-0.40%
(-0.080) 1D
Nov 17, 3:04:25โ€ฏPM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300529...
Open
CNยฅ20.05
High
CNยฅ20.36
Low
CNยฅ19.95
Mkt. cap
16.15B
Avg. vol.
10.74M
Volume
9.16M
Dividend
2.58%
Quarterly dividend
CNยฅ0.13
Ex-dividend date
Jun 1, 2026
P/E ratio
23.98
52-wk high
CNยฅ21.38
52-wk low
CNยฅ14.60
EPS
CNยฅ0.84
Shares outstanding
798.61M
No. of employees
2K
Open
CNยฅ20.05
High
CNยฅ20.36
Low
CNยฅ19.95
Mkt. cap
16.15B
Avg. vol.
10.74M
Volume
9.16M
Dividend
2.58%
Quarterly dividend
CNยฅ0.13
Ex-dividend date
Jun 1, 2026
P/E ratio
23.98
52-wk high
CNยฅ21.38
52-wk low
CNยฅ14.60
EPS
CNยฅ0.84
Shares outstanding
798.61M
No. of employees
2K
News stories
From web sources and news partners
About Jafron Biomedical Co Ltd
CEO-
Employees2.2K
FoundedDec 19, 1989
Headquarters-
SectorHealth Care
IndustryMedical device
Websitejafron.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
455.80M
560.62M
471.85M
578.08M
Cost of goods sold
122.83M
127.54M
110.75M
105.16M
Cost of revenue
122.83M
127.54M
110.75M
105.16M
Research and development expenses
51.42M
45.69M
57.40M
53.25M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
135.77M
115.42M
117.22M
155.89M
Operating expense
197.92M
166.90M
187.46M
207.81M
Total operating expenses
320.75M
294.44M
298.21M
312.98M
Operating income
135.05M
266.18M
173.64M
265.10M
Other non operating income
3.02M
-1.18M
325.24K
-4.10M
EBT including unusual items
108.07M
260.01M
187.12M
228.15M
EBT excluding unusual items
171.31M
258.91M
167.29M
257.05M
Income tax expense
28.26M
39.37M
24.78M
34.99M
Effective tax rate
26.15%
15.14%
13.24%
15.34%
Other operating expenses
8.52M
4.18M
13.61M
-1.84M
Net income
79.59M
220.51M
161.46M
192.68M
Net profit margin
17.46%
39.33%
34.22%
33.33%
Earnings per share
-
-
-
-
Interest and investment income
48.69M
6.26M
9.06M
5.60M
Interest expense
-13.28M
-12.35M
-12.43M
-12.86M
Net interest expenses
35.41M
-6.09M
-3.37M
-7.26M
Depreciation and amortization charges
-
-
-
-
EBITDA
164.34M
295.47M
203.48M
294.39M
Gain or loss from assets sale
79.85K
-
-113.20K
113.20K
Upcoming events
AI content may include mistakes. Learn more
Google apps